Moreover, activation of the AMPK/PGC-1α pathway promotes interactions with mitochondrial proteins that enhance mitochondrial quality by improving mitophagy (the removal of damaged mitochondria) and maintaining balanced mitochondrial dynamics (fusion and fission)—processes closely linked to the progression of various metabolic diseases [29]. This evidence concerns the gene PPARGC1A and metabolic disease.